Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019

MMWR. Morbidity and mortality weekly report - United States
doi 10.15585/mmwr.mm6846a4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centers for Disease Control MMWR Office

Related search

Problems in the Therapy for Imported Malaria in the United States

Archives of Internal Medicine
2003English

Structural Interventions for HIV Prevention in the United States

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Men With Possible Zika Virus Exposure — United States, August 2018

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2018English

Tuberculosis — United States, 2019

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2020English

Editorial: Drugs for Prevention of Malaria.

BMJ
1974English

Male Circumcision for Prevention of HIV Transmission: What the New Data Mean for HIV Prevention in the United States

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2007English

Vital Signs: Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2019English

Directly Observed Therapy and Treatment Completion for Tuberculosis in the United States: Is Universal Supervised Therapy Necessary?

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Dietary Goals for the United States

Nutrition Reviews
MedicineNutritionDietetics
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy